134 related articles for article (PubMed ID: 38117087)
1. Hematopoietic Bone Marrow Transplant to Treat Systemic EBV-positive T-cell Lymphoma of Childhood.
Manini N; Davidow K; Conard K; Powell J
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e208-e211. PubMed ID: 38117087
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults.
Wang Z; Kimura S; Iwasaki H; Takase K; Oshiro Y; Gamachi A; Makihara K; Ogata M; Daa T; Momosaki S; Takamatsu Y; Takeshita M
Diagn Pathol; 2021 Jun; 16(1):48. PubMed ID: 34088321
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America.
Coffey AM; Lewis A; Marcogliese AN; Elghetany MT; Punia JN; Chang CC; Allen CE; McClain KL; Gaikwad AS; El-Mallawany NK; Curry CV
Pediatr Blood Cancer; 2019 Aug; 66(8):e27798. PubMed ID: 31099136
[TBL] [Abstract][Full Text] [Related]
5. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Xu L; Liu X; Wang Y; Wang Y; Chu X; Chen L
Medicine (Baltimore); 2022 Mar; 101(9):e28943. PubMed ID: 35244052
[TBL] [Abstract][Full Text] [Related]
7. EBV-positive T/NK-associated lymphoproliferative disorders of childhood: A complete autopsy report.
Keow JY; Stecho WM; Haig AR; Sangle NA
Indian J Pathol Microbiol; 2020; 63(1):78-82. PubMed ID: 32031127
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
Yu M; Zhang Q; Xu S; Yin T; Li F
Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
11. Unrelated bone marrow transplantation induced long-term remission in a patient with life-threatening Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kunitomi A; Kimura H; Ito Y; Naitoh K; Noda N; Iida H; Sao H
J Clin Exp Hematop; 2011; 51(1):57-61. PubMed ID: 21628862
[TBL] [Abstract][Full Text] [Related]
12. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Li Z; Wang Y; Wang J; Zhang J; Wang Z
Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
[TBL] [Abstract][Full Text] [Related]
14. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
16. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.
Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A
Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Su IJ; Wang CH; Cheng AL; Chen RL
Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
19. Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders.
Onishi Y; Onodera K; Fukuhara N; Kato H; Ichikawa S; Fujiwara T; Yokoyama H; Yamada-Fujiwara M; Harigae H
Int J Hematol; 2022 Jun; 115(6):873-881. PubMed ID: 35274195
[TBL] [Abstract][Full Text] [Related]
20. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
